Voriconazole Suspension
Product Images NDC 40032-038

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 40032-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novel Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (5adeb65f 1fe8 4aef B2c8 C119e03f211c 01)

Chemical structure of voriconazole, showing its triazole and fluorinated aromatic rings along with hydroxyl and methyl groups.*

FDA Label Image

Adapter And Syringe (5adeb65f 1fe8 4aef B2c8 C119e03f211c 02)

An instructional line drawing showing hands opening a child-resistant cap on a small bottle, demonstrating the push-down-and-turn mechanism to open the container typically used for oral suspension medications.*

FDA Label Image

Image 2 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 03)

An instructional illustration showing hands opening a bottle by twisting off the cap, with arrows indicating the direction of movement for removing the closure. This diagram likely demonstrates how to open a suspension bottle, such as VORICONAZOLE oral suspension.*

FDA Label Image

Image 3 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 04)

An illustration showing the top portion of a medication bottle with a child-resistant screw cap design. The bottle appears partially filled with liquid, indicating a suspension form.*

FDA Label Image

Image 4 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 05)

An instructional illustration showing a person using an oral syringe to measure liquid medication. The image demonstrates drawing suspension from a bottle with an arrow indicating the movement of the syringe plunger upward to fill the syringe with medication.*

FDA Label Image

Image 5 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 06)

An instructional illustration showing a hand holding a syringe or dropper bottle top, drawing or preparing to draw liquid medication from an open bottle. The image likely demonstrates the proper method for measuring or extracting oral suspension dosage.*

FDA Label Image

Image 6 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 07)

An instructional illustration showing a person using a syringe to extract liquid medication from a bottle. One hand holds the bottle steady while the other hand pulls the syringe plunger to draw the suspension out. This image likely demonstrates how to measure or administer an oral suspension medication.*

FDA Label Image

Image 7 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 08)

An instructional illustration showing a hand pouring oral suspension medication into a dosing syringe held by the other hand, demonstrating how to fill the syringe for oral administration.*

FDA Label Image

Image 8 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 09)

An instructional illustration showing a hand using a syringe to withdraw oral suspension medication from a bottle. The image depicts the proper technique for extracting liquid medication from the container.*

FDA Label Image

Image 9 (5adeb65f 1fe8 4aef B2c8 C119e03f211c 10)

An instructional line drawing showing two hands opening a child-resistant cap on a small oral suspension bottle. One hand holds the bottle steady while the other hand presses down and turns the cap to open it.*

FDA Label Image

Container Label (5adeb65f 1fe8 4aef B2c8 C119e03f211c 11)

Voriconazole for Oral Suspension 40 mg/mL, orange-flavored, in a 49 g (75 mL when reconstituted) bottle. The label includes directions for reconstitution and storage, dosage instructions, and cautions. The product is labeled for prescription use only and manufactured by Novel Laboratories, Inc., Somerset, NJ.*

FDA Label Image

Carton (5adeb65f 1fe8 4aef B2c8 C119e03f211c 12)

Packaging label for Voriconazole oral suspension 40 mg/mL by Novel Laboratories, Inc. The orange-flavored medication comes with an oral dispenser and contains 49 g (75 mL when reconstituted). Instructions include storage conditions before and after reconstitution, mixing directions, and a discard timeline of 14 days after reconstitution. The label includes NDC 40032-038-60 and manufacturer details in Somerset, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.